TrialX
Image

Prevalence of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) Following Squamous Cell Carcinomas of the Oropharynx Treatment by Combined Chemoradiotherapy

Prevalence of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) Following Squamous Cell Carcinomas of the Oropharynx Treatment by Combined Chemoradiotherapy

Recruiting
18 years and older
All
Phase N/A

Overview

The study's aim is to determinate the prevalence of obstructive sleep apnea hypopnea syndrome after treatment by combined chemoradiotherapy in a locally advanced stages treated population of oropharyngeal cancer. Indeed, the level of knowledge about the consequences of oropharyngeal cancer treatment on sleep quality remains poor but the few studies published on the subject suggest an increased risk of development of OSAHS for these patients.

Eligibility

Inclusion Criteria:

  • Age> 18 years old
  • Performance Status 0-2
  • Squamous cell carcinoma of the oropharynx treated with concomitant chemoradiotherapy
  • Treatment termination time greater than 6 months at inclusion
  • Tumor classification (American Joint Committee on Cancer 8th) T2-T4 N0-N3
  • Patient in complete remission at inclusion
  • patient's consent's obtained after information

Exclusion Criteria:

  • Previous treatment for upper aerodigestive tract cancer
  • Incomplete radiotherapyTreatment
  • Neurological pathology wich may affect the functions of the upper aerodigestive tract
  • Pregnant or breastfeeding woman
  • Unweaned alcoholism
  • Tracheotomized patient at the time of the study
  • Patient under protection: subjects with guardianship or under law protection
  • No health insurance coverage

Study details
    Oropharyngeal Cancer
    Obstructive Sleep Apnea-hypopnea

NCT04440618

Poitiers University Hospital

16 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.